Mohammad S., SiddiquiArun J., Sanyal. Drug Therapy for NASH: Insulin-Sensitizing Agents (Metformin and Thiazolidinediones). 2013:, 271-283. /Mohammad S. Siddiqui , Arun J. Sanyal . 2013. Drug Therapy for NASH: Insulin-Sensitizing Agents (Metformin and Thiazolidinediones). Non-Alcoholic Fatty ...
Non-alcoholic steatohepatitis (NASH) is an increasingly common cause of cirrhosis, hepatocellular carcinoma, and liver-related death (LRD). Consequently, there is a critical need for effective drug therapy that improves clinically relevant end-points. Hepatic steatosis assessed by magnetic resonance imagi...
"We are glad to receive the clinical trial approval of XW003 for NASH therapy by China NMPA," saidHai Pan, PhD, Sciwind's founder and CEO. "Obesity, diabetes and NASH are a collection of closely related, chronic metabolic disorders sharing similar pathogenesis. XW003 can improve t...
Forty-one recurrent tension headache sufferers were randomly assigned to either cognitive-behavioral therapy (administered in a primarily home-based treatm... KA Holroyd,JM Nash,JD Pingel,... - 《Journal of Consulting & Clinical Psychology》 被引量: 191发表: 1991年 Neurostimulation therapies for ...
AbstractforCurrent eradication rate of Helicobacter pylori with clarithromycin-based triple therapy in a gastroenterology practice in the New York metropolitan area | Full Text | References | PDF (149.9 KB) 81 Views 11 CrossRef citations Altmetric Article Skin bacterial flora as a potential risk fa...
Browning markers, inflammation and fibrosis markers, and NASH markers were analyzed from ArrayExpress with accession numbers E-GEOD-8044, E-MEXP-980, E-GEOD-58979, respectively. All gene signatures are listed in Supplementary Table 3. RNA-seq data for WAT from mice treated with chikusetsusaponin...
A natural polysaccharide mediated MOF-based Ce6 delivery system with improved biological properties for photodynamic therapy[J]. J Mater Chem B, 2020, 8(7): 1481-1488. doi: 10.1039/C9TB02482D [35] Ni K, Luo T, Nash GT, et al. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy...
However, the treatment of obesity itself has proven largely resistant to therapy, with anti-obesity medications (AOMs) often delivering insufficient efficacy and dubious safety. Here, we provide an overview of the history of AOM development, focusing on lessons learned and ongoing obstacles. Recent ...
Non-alcoholic steatohepatitis (NASH) is a liver disease currently lacking an approved therapy, resulting in significant clinical demand. Traditional Chinese medicines (TCMs) have been commonly used to manage NASH. This study aimed to systematically analyse the randomised controlled trials (RCTs) using ...
Synthetic biology-inspired cell engineering in diagnosis, treatment and drug development Article Open access 11 March 2023 Engineering cells for therapy and diagnosis Article 19 June 2024 Next-generation stem cells — ushering in a new era of cell-based therapies Article 06 April 2020 References...